Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Thyroid carcinoma
|
145 | 0.474 | 0.800 | 19 | 43553422 | missense variant | G/A | snv | 9.5E-02 | 7.0E-02 | 0.060 | 0.667 | 6 | 2012 | 2019 | ||||
Thyroid Neoplasm
|
135 | 0.474 | 0.800 | 19 | 43553422 | missense variant | G/A | snv | 9.5E-02 | 7.0E-02 | 0.060 | 0.667 | 6 | 2012 | 2019 | ||||
Xeroderma Pigmentosum, Complementation Group D
|
111 | 0.474 | 0.800 | 19 | 43553422 | missense variant | G/A | snv | 9.5E-02 | 7.0E-02 | 0.060 | 1.000 | 6 | 2006 | 2011 | ||||
cervical cancer
|
268 | 0.474 | 0.800 | 19 | 43553422 | missense variant | G/A | snv | 9.5E-02 | 7.0E-02 | 0.050 | 0.600 | 5 | 2008 | 2017 | ||||
Cervix carcinoma
|
283 | 0.474 | 0.800 | 19 | 43553422 | missense variant | G/A | snv | 9.5E-02 | 7.0E-02 | 0.050 | 0.600 | 5 | 2008 | 2017 | ||||
Malignant tumor of cervix
|
245 | 0.474 | 0.800 | 19 | 43553422 | missense variant | G/A | snv | 9.5E-02 | 7.0E-02 | 0.050 | 0.600 | 5 | 2008 | 2017 | ||||
Nasopharyngeal carcinoma
|
320 | 0.474 | 0.800 | 19 | 43553422 | missense variant | G/A | snv | 9.5E-02 | 7.0E-02 | 0.050 | 0.600 | 5 | 2006 | 2018 | ||||
Neoplasms
|
1644 | 0.474 | 0.800 | 19 | 43553422 | missense variant | G/A | snv | 9.5E-02 | 7.0E-02 | 0.050 | 0.800 | 5 | 2005 | 2017 | ||||
Head and Neck Carcinoma
|
118 | 0.474 | 0.800 | 19 | 43553422 | missense variant | G/A | snv | 9.5E-02 | 7.0E-02 | 0.040 | 0.500 | 4 | 2009 | 2014 | ||||
Lymphoma, Non-Hodgkin
|
197 | 0.474 | 0.800 | 19 | 43553422 | missense variant | G/A | snv | 9.5E-02 | 7.0E-02 | 0.040 | 1.000 | 4 | 2007 | 2016 | ||||
Malignant Head and Neck Neoplasm
|
118 | 0.474 | 0.800 | 19 | 43553422 | missense variant | G/A | snv | 9.5E-02 | 7.0E-02 | 0.040 | 0.500 | 4 | 2009 | 2014 | ||||
Malignant neoplasm of prostate
|
1082 | 0.474 | 0.800 | 19 | 43553422 | missense variant | G/A | snv | 9.5E-02 | 7.0E-02 | 0.040 | 0.500 | 4 | 2007 | 2014 | ||||
Prostate carcinoma
|
1168 | 0.474 | 0.800 | 19 | 43553422 | missense variant | G/A | snv | 9.5E-02 | 7.0E-02 | 0.040 | 0.500 | 4 | 2007 | 2014 | ||||
Alzheimer's Disease
|
1843 | 0.474 | 0.800 | 19 | 43553422 | missense variant | G/A | snv | 9.5E-02 | 7.0E-02 | 0.030 | 1.000 | 3 | 2007 | 2016 | ||||
Carcinogenesis
|
355 | 0.474 | 0.800 | 19 | 43553422 | missense variant | G/A | snv | 9.5E-02 | 7.0E-02 | 0.030 | 1.000 | 3 | 2003 | 2005 | ||||
Coronary Artery Disease
|
1577 | 0.474 | 0.800 | 19 | 43553422 | missense variant | G/A | snv | 9.5E-02 | 7.0E-02 | 0.030 | 1.000 | 3 | 2014 | 2017 | ||||
Diffuse Large B-Cell Lymphoma
|
127 | 0.474 | 0.800 | 19 | 43553422 | missense variant | G/A | snv | 9.5E-02 | 7.0E-02 | 0.030 | 1.000 | 3 | 2007 | 2016 | ||||
Esophageal carcinoma
|
272 | 0.474 | 0.800 | 19 | 43553422 | missense variant | G/A | snv | 9.5E-02 | 7.0E-02 | 0.030 | 1.000 | 3 | 2009 | 2013 | ||||
Esophageal Neoplasms
|
270 | 0.474 | 0.800 | 19 | 43553422 | missense variant | G/A | snv | 9.5E-02 | 7.0E-02 | 0.030 | 1.000 | 3 | 2009 | 2013 | ||||
Malignant neoplasm of esophagus
|
214 | 0.474 | 0.800 | 19 | 43553422 | missense variant | G/A | snv | 9.5E-02 | 7.0E-02 | 0.030 | 1.000 | 3 | 2009 | 2013 | ||||
Malignant neoplasm of skin
|
38 | 0.474 | 0.800 | 19 | 43553422 | missense variant | G/A | snv | 9.5E-02 | 7.0E-02 | 0.030 | 0.667 | 3 | 2004 | 2011 | ||||
Papillary thyroid carcinoma
|
204 | 0.474 | 0.800 | 19 | 43553422 | missense variant | G/A | snv | 9.5E-02 | 7.0E-02 | 0.030 | 1.000 | 3 | 2011 | 2018 | ||||
Squamous cell carcinoma of esophagus
|
329 | 0.474 | 0.800 | 19 | 43553422 | missense variant | G/A | snv | 9.5E-02 | 7.0E-02 | 0.030 | 1.000 | 3 | 2002 | 2009 | ||||
Carcinoma, Ovarian Epithelial
|
327 | 0.474 | 0.800 | 19 | 43553422 | missense variant | G/A | snv | 9.5E-02 | 7.0E-02 | 0.020 | 1.000 | 2 | 2013 | 2015 | ||||
Carcinoma, Transitional Cell
|
12 | 0.474 | 0.800 | 19 | 43553422 | missense variant | G/A | snv | 9.5E-02 | 7.0E-02 | 0.020 | 1.000 | 2 | 2014 | 2015 |